DFG
ABBV icon

Demars Financial Group’s AbbVie ABBV Stock Holding History

Demars Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,961
Closed -$1.34M – 74
2023
Q2 		$1.34M Sell
9,961
-563
-5% -$82.6K 0.75% 32
2023
Q1 		$1.68M Sell
10,524
-980
-9% -$150K 0.92% 26
2022
Q4 		$1.86M Sell
11,504
-962
-8% -$148K 1.03% 28
2022
Q3 		$1.67M Buy
12,466
+5,020
+67% +$720K 0.99% 29
2022
Q2 		$1.14M Sell
7,446
-2,200
-23% -$336K 0.65% 39
2022
Q1 		$1.56M Sell
9,646
-450
-4% -$65.4K 0.79% 33
2021
Q4 		$1.37M Buy
10,096
+6,783
+205% +$801K 0.72% 38
2021
Q3 		$357K Sell
3,313
-576
-15% -$65.8K 0.21% 66
2021
Q2 		$438K Buy
3,889
+100
+3% +$11.3K 0.26% 60
2021
Q1 		$410K Sell
3,789
-10
-0.3% -$1.07K 0.28% 58
2020
Q4 		$407K Sell
3,799
-25
-0.7% -$2.4K 0.29% 53
2020
Q3 		$335K Buy
3,824
+254
+7% +$23.9K 0.26% 48
2020
Q2 		$351K Buy
3,570
+135
+4% +$11.9K 0.29% 45
2020
Q1 		$262K Buy
+3,435
New +$293K 0.27% 43

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Demars Financial Group's ABBV Position: Q3 2023 in Review

Demars Financial Group sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 9,961 shares — an estimated $1.34M sold.

Demars Financial Group first reported a position in ABBV in Q1 2020 and held it in 14 quarters. The position peaked at $1.86M in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Demars Financial Group reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Demars Financial Group sold 9,961 AbbVie shares in Q3 2023, an estimated $1.34M.
  • Demars Financial Group first reported a position in AbbVie in Q1 2020 and held it in 14 quarters.
  • Demars Financial Group's AbbVie position peaked at $1.86M in Q4 2022.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Demars Financial Group's 13F filing for Q3 2023, filed 18 Oct 2023.